Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herbapect
- Development stage
- Unknown
- Lead developer
- Aflofarm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Herbapect is an herbal combination cough syrup developed and marketed by Aflofarm Farmacja Polska. It contains three active ingredients: thyme herb liquid extract (*Thymus vulgaris* L.), cowslip tincture (*Primula veris* L.), and sulfogaiacol (potassium guaiacolsulfonate). Indicated for the treatment of upper respiratory tract infections, it acts as an expectorant to alleviate persistent dry cough and facilitate the clearing of mucus. The product is an over-the-counter (OTC) medication widely used in Poland and is formulated as a sugar-free syrup suitable for diabetics, although it contains small amounts of ethanol and sorbitol.
- Brand names
- Herbapect
- Other names
- Herbapect syrup
Beyond the preview
Go deeper on Herbapect.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Herbapect.